TO EVALUATE THE ROLE OF CANNABINOID SIGNALING DURING THE COMORBIDITY OF HIV AND ALZHEIMER¬øS DISEASE IN THE CONTEXT OF HIV-ASSOCIATED COGNITIVE DISORDERS